Alemtuzumab-induced elimination of HIV-1-infected immune cells

K Ruxrungtham, S Sirivichayakul, S Buranapraditkun, W Krause

Why CMV is a candidate for elimination and then eradication

Paul D Griffiths & T Mahungu

Supplement 4: The HIV epidemic in South-east Asia: initial responses towards the UNAIDS 90–90–90 goal

Edited by, N Kumarasamy, RN Pendse

Efforts to eliminate the latent reservoir in resting CD4+ T cells: strategies for curing HIV-1 infection

Ya-Chi Ho & Janet D Siliciano

Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen

Matthew Bates & Arne Broch Brantsaeter

Guest editorial: Children are not small adults

Caroline Foster & Hermione Lyall

Novel immunological strategies for HIV-1 eradication

B Jülg & DH Barouch

HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence

F Maldarelli

Treatment strategies for Middle East respiratory syndrome coronavirus

Kayvon Modjarrad

Human cytomegalovirus and transplantation: drug development and regulatory issues

Megan McIntosh, Benjamin Hauschild, Veronica Miller

Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?

M Martinez-Bonet, MI Clemente, MJ Serrami­a, et al.

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

P Palma, C Foster, P Rojo, et al

The HIV cure research agenda: the role of mathematical modelling and cost-effectiveness analysis

KA Freedberg, C Possas, S Deeks, et al.

HIV pre-exposure prophylaxis for women

Anandi N Sheth, Charlotte P Rolle, Monica Gandhi

HCV cure for everyone or which challenges remain?

Jürgen Rockstroh

Host factors and early treatments to restrict paediatric HIV infection and early disease progression

Ketty Gianesen, Raffaella Petrara, Riccardo Freguja, et al.

Paediatric HIV infection in the ‘omics era: defining transcriptional signatures of viral control and vaccine responses

Nicola Cotugno, Lesley De Armas, Suresh Pallikkuth, et al

Participation in HIV cure-related research: a scoping review of the proxy literature and implications for future research

K Dubé, C Ramirez, J Handibode, et al.

HIV-1 prophylactic vaccines: state of the art

Jean-Daniel Lelièvre & Yves Lévy

The growing HIV epidemic in Central Europe: a neglected issue?

Deniz Gökengin, Cristiana Opera, Serhat Uysal, Josip Begavac

The role of miR-29a in HIV-1 replication and latency

Giacomo Frattari, Lars Aagaard, Paul W Denton

HIV AIDS in the South-East Asia region: progress and challenges

Razia Pendse, Somya Gupta, Dongbao Yu, Swarup Sardar

The role of HPV testing in global cervical cancer prevention strategies: Proceedings of a symposium supported by Cepheid (Sunnyvale, CA, USA) and held at the 31st International Papillomavirus Conference

Louise Kuhn, Heather Cubie, David Hawkes, Andrew Valley

Adverse bone health among children and adolescents growing up with HIV

Tavitiya Sudjaritruk & Thanyawee Puthanakit

Higher risks of mother-to-child HIV transmission in countries with lower HIV prevalence: UNAIDS 2013 results for 32 countries with generalised epidemics

A Hill, T Dauncey, J Levi, K Heath, C Pérez Casas

Diagnostic utility of droplet digital PCR for HIV reservoir quantification

Wim Trypsteen, Maja Kiselinova, Linos Vandekerckhove, Ward De Spiegelaere

Oral PrEP for HIV prevention. It works

Erica Pool, Elaney Youssef, Martin Fisher

Deep sequencing of HIV-1 variants from paired plasma and CSF during primary HIV infection

A Gega, MJ Kozal, J Chiarella, et al.

‘I can coexist with HIV’: a qualitative study of perceptions of HIV cure among people living with HIV in Guangzhou, China

Qingyan Ma, Feng Wu, Gail Henderson, Stuart Rennie, Zachary C Rich, Yu Cheng, Weiping Cai, Fengyu Hu, Joseph D Tucker

HIV-1 co-receptor tropism and disease progression in children and young adults with perinatally acquired HIV-1 infection. The HICCUP Study

C Foster, S Kaye, C Smith, NE Mackie

Towards a scalable HIV cure research agenda: the role of co-infections

I Sereti, GK Folkers, G Meintjes, DR Boulware

The use of HIV-1 integration site analysis information in clinical studies aiming at HIV cure

Maja Kiselinova, Ward De Spiegelaere, Linos Vandekerckhove

HCV treatment in children and young adults with HIV-HCV co-infection in Europe

Anna Turkova, Vania Giacomet, Tessa Goetghebuer, et al

The hepatitis C treatment revolution: how to avoid Asia missing out

N Walsh, N Durier, G Khwairakpam, et al.

Editorial: HIV cure research

Jintanat Ananworanich & Anthony Fauci

Immune checkpoints and the HIV-1 reservoir: proceed with caution

Rikke Olesen, Steffan Leth, Rasmus Nymann, Lars Østergaard, Ole S Søgaard, Paul W Denton, Martin Tolstrup

HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?

Deanna A Kulpa & Nicolas Chomont

IAS Towards an HIV Cure Symposium: people focused, science driven 18–19 July 2015, Vancouver, Canada

S Fidler, J Thornhill, E Malatinkova, et al.

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

Torsak Bunupuradah, Passorn Punyahotra, Tim R Cressey, et al

Hepatitis B virus genotypes A and D in Uganda

JT Zirabamuzale, CK Opio, F Bwanga, et al.

What's new for antiretroviral treatment in women

Nisha Andany & Sharon Walmsley

The difficulties of ‘living while girl’

Judith Bruce

How can we achieve universal access to low-cost treatment for HIV?

Andrew M Hill & Anton L Pozniak

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation

Jonathan Liu, Pedro Goicochea, Timothy Block, Carol L Brosgart, Eric F Donaldson, Oliver Lenz, Seng Gee Lim, Ed G Marins, Poonam Mishra, Marion G Peters, Veronica Miller

The complex legal and ethical issues related to generic medications. Viral hepatitis: a case study

Mark Danta & N Ghinea

Towards an ideal antiretroviral regimen for the global HIV epidemic

Beatriz Grinsztejn, Lara E Coelho, Paula M Luz, Valdilea G Veloso

The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries

Andrew M Hill, Sanjay Nath, Bryony Simmons

The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000–2014

Suchada Chaivooth, Sorakij Bhakeecheep, Kiat Ruxrungtham, Sirinya Teeraananchai, Stephen J Kerr, Achara Teeraratkul, Petchsri Sirinirund, Sumet Ongwandee, Anchalee Avihingsanon, Patchara Benjarattanaporn, Nittaya Phanuphak, Somnuek Sungkanuparph, Sophon Mekthon, Praphan Phanuphan

The impact of Thailand‘s public health response to the HIV epidemic 1984–2015: understanding the ingredients of success

Taweesap Siraprapasiri, Sumet Ongwangdee, Patchara Benjarattanaporn, Wiwat Peerapatanapokin, Mukta Sharma

Knowledge, attitude and practice of medical laboratory practitioners in the fight against Ebola virus disease

Kabir M Hamid, Ibrahim Yusuf, Bernard A Onoja, Abdullahi Y Koki

The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study

O Wittawatmongkol, TJ Mohamed, TPK Le, et al

International Congress on Targeting Ebola 28–29 May 2015, Pasteur Institute, Paris

S Kinloch & CS Brown

Highlights from the 2016 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 25–27 May 2016, Marseille, France

Jean-Pierre Routy, Christina Psomas, Vicente Soriano, Patrick Phillibert, Hervé Tissot-Dupont, Alain Lafeuillade

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children

Jintanat Ananworanich, Stephen J Kerr, Tanyathip Jaimulwong, et al

Barriers and best practices of transitioning perinatally HIV-infected adolescents to adult care in Asia-Pacific

T Bunupuradah, B Thongpunchang, P Nipathakosol

Abstracts of the 2016 International Symposium on HIV and Emerging Diseases (ISHEID)

Follow the link to download the pdf

India‘s HIV programme: successes and challenges

Sukarma Tanwar, BB Rewari, CV Dharma Rao, Nicole Seguy

Treating hepatitis C virus in children: time for a new paradigm

Claire Thorne, Giuseppe Indolfi, Anna Turkova, et al

Ebola in children: a personal perspective

Tejshri Shah

Viruses and exacerbations of chronic obstructive pulmonary disease: unmet clinical need

Lewis Buss & John Hurst

Current trends in Zika vaccine development

Francisco A Lagunas-Rangel, Martha E Viveros-Sandoval, Arturo Reyes-Sandoval

High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C

Andrew Hill, Giten Khwairakpam, James Wang, Sergey Golovin, Julia Dragunova, Rachel Smith, Vicky Houghton-Price, Roxanna Korologou-Linden, Sanjay Nath, Anna Savage, Greg Jefferys

Evolution of the health sector response to HIV in Myanmar: progress, challenges and the way forward

Htun Nyunt Oo, San Hone, Masami Fujita, et al

Second European Round Table on the Future Management of HIV 10–11 October 2014, Barcelona, Spain

Casper Rokx, Douglas Richman, Michaela Mueller-Trutwin, et al.

50th International Liver Congress: update on viral hepatitis 22–26 April 2015, Vienna, Austria

Morven Cunningham & Douglas Macdonald

Highlights from the Keystone Symposium on HIV Persistence 2015 26–30 April 2015, Boston, Massachusetts, USA

Sulggi Lee

Highlights from the Children’s HIV Association Conference 22 May 2015, Leicester

Srini Bandi

Towards the elimination and eradication of hepatitis B

Geoffrey Dusheiko

Control of HIV viraemia is not enough in perinatal HIV

Caroline Foster & Sarah Fidler

CNS reservoirs for HIV: implications for eradication

Joanna Hellmuth, Victor Valcour, Serena Spudich

A qualitative assessment of barriers and facilitators to ART adherence in Thai patients

M Phuphanich, M Rattanamahattana, A Avihingsanon, et al.

The X awakens: multifactorial ramifications of sex-specific differences in HIV-1 infection

Sven Hagen & Marcus Altfeld

Cytomegalovirus vaccines under clinical development

Mark Schleiss

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection

Suha Saleh, Lenard Vranckx, Rik Gijsbers, Frauke Christ, Zeger Debyser

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations

Samuel A Garner, Stuart Rennie, Jintanat Ananworanich, Karine Dube, David M Margolis, Jeremy Sugarman, Randall Tressler, Adam Gilbertson, Liza Dawson

Factors associated with intention to take non-occupational HIV post-exposure prophylaxis among Thai men who have sex with men

Nitiya Chomchey, Thira Woratanarat, Narın Hiransuthikul, Somrat Lertmaharit, Vitool Lohsoonthorn, Nipat Teeratakulpisarn, Suteeraporn Pinyakorn, James LK Fletcher, Duanghathai Suttichom, Praphan Phanuphak, Jintanat Ananworanich, Nittaya Phanuphak

Low-level genital HIV shedding in Thai HIV-infected women with suppressed plasma viral load after menopause: a longitudinal study

Nadia Kancheva Landolt, Tanya Do, Naruporn Kasipong, Rosalin Kriengsinyot, Sasiwimol Ubolyam, Apicha Mahanontharit, Tippawan Pankam, Tanakorn Apornpong, Anchalee Avihingsanon, Jintanat Ananworanich, Nittaya Phanuphak, Surasith Chaithongwongwatthana

From the Millennium Development Goals to Sustainable Development Goals. The response to the HIV epidemic in Indonesia: challenges and opportunities

Fetty Wijayanti, Siti Nadia Tarmizi, Viny Tobing, et al

Effect of calcium and vitamin D supplementation on bone mineral accrual among HIV-infected Thai adolescents with low bone mineral density

Thanyawee Puthanakit, Orasri Wittawatmongkol, Voraporn Poomlek, Tavitiya Sudjaritruk, Chantaphat Brukesawan, Torsak Bunupuradah, Sirintip Sricharoenchai, Thongsuai Chuanjaroen, Wasana Prasitsuebsai, Kulkanya Chokephaibulkit

HIV disclosure and stigma among women living with HIV in Denmark

Maria Wessman, Kristina Thorsteinsson, Merete Storgaard, Frederikke F Rönsholt, Isik S Johansen, Gitte Pedersen, Lars N Nielsen, Nina Wies, Terese L Katzenstein, Anne-Mette Lebech

Changes in the haematological parameters of HIV-1 infected children at 6 and 12 months of antiretroviral therapy in a large clinic cohort, North-Central Nigeria

Augustine O Ebonyi, Stephen Oguche, Martha O Ochoga, Oche O Agbaji, Joseph A Anejo-Okopi, Isaac O Abah, Prosper I Okonkwo, John A Idoko

Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8–11 December 2015, Miami, Florida, USA

DM Margolis, K Salzwedel, N Chomont, et al.

HIV-1 resistance to dolutegravir: update and new insights

Mark Wainberg & Ying-Shan Han

A success story: identified gaps and the way forward for low HIV prevalence in Bangladesh

Md Kamar Rezwan, Hussain Sarwar Khan, Tasnim Azim, et al

Clinical outcomes and antiretroviral therapy in ‘elite’ controllers: a review of the literature

Trevor A Crowell & Hiroyu Hatano

Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C

A Hill, B Simmons, D Gotham, et al.

Contraceptive challenges in adolescents living with or at risk of HIV

N Kancheva Landolt, T Bunupuradah, S Chaithongwongwatthana

Cytomegalovirus and paediatric HIV infection

Jennifer Slyker

A CD3|CD28 microbead-based HIV-1 viral outgrowth

Yuri V Kuzmichev, Rebecca T Veenhuis, Christopher W Pohlmeyer, Caroline C Garliss, Victoria EK Walker-Sperling, Joel N Blankson

Factors associated with early menopause among women in Nigeria

Patricia Agaba, Seema Meloni, Halima Sule, Amaka Ocheke, Emmanuel Agaba, John Idoko, Phyllis Kanki

The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research

Vikram Mehraj, Peter Ghali, Rayoun Ramendra, Cecilia Costiniuk, Bertrand Lebouché, Rosalie Ponte, Robert Reinhard, Jose Sousa, Nicolas Chomont, Eric A Cohen, Petronela Ancuta, Jean-Pierre Routy

HIV rapid diagnostic testing by lay providers in a key population-led health service programme in Thailand

Rapeeporn Wongkanya, Tippawan Pankam, Shauna Wolf, Supanit Pattanachaiwit, Jureeporn Jantarapakde, Supabhorn Pengnongyang, Prasopsuk Thapwong, Apichat Udomjirasirichot, Yutthana Churattanakraisri, Nanthika Praweperay, Apiluk Paksornsit, Thidadaow Sitthipau, Sarayut Petchaithong, Raruay Jitsakulchaidejt, Somboon Nookhai, Cheewanan Lerpiriyasuwaty, Sumet Ongwandee, Praphan Phanuphak, Nittaya Phanuphak

Strategies to improve the uptake of effective contraception in perinatally HIV-infected adolescents

Nadia Kancheva Landolt, Jullapong Achalapong, Pope K Kosalaraksa, Witaya Petdachai, Chaiwat Ngampiyaskul, Stephen Kerr, Pongrak Boonyanurak, Jintanat Ananworanich, Torsak Bunupuradah

InterPrEP. Internet-based pre-exposure prophylaxis with generic tenofovir DF and emtricitabine in London: an analysis of outcomes in 641 patients

Isaac Aloysius, Anna Savage, Jey Zdravkov, Roxanna Korologou-Linden, Andrew Hill, Rachel Smith, Vicky Houghton-Price, Marta Boffito, Nneka Nwokolo

Epidemiology of HIV, programmatic progress and gaps in last 10 years in Nepal

Tarun Paudel, Nihal Singh, Megha Raj Banjara, et al

Animal models in the quest for virus eradication

Luca Micci, Colleen S McGary, Mirko Paiardini

Transgender populations and HIV: unique risks, challenges and opportunities

T Wansom, TE Guadamuz, S Vasan

Ageing and menopause considerations for women with HIV in the UK

Lorraine Sherr, Aoife Molloy, Ana Macedo, Natasha Crome, Margaret A Johnson

Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients

Maura Manion, Bruno B Andrade, Rebecca DerSimonian, Wenjuan Gu, Adam Rupert, Laura W Musselwhite, Juan G Sierra-Madero, Pablo F Belaunzaran-Zamudio, Ian Sanne, Michael M Lederman, Irini Sereti

The ‘post-condom era’ or the urgent need to provide effective contraception for women living with HIV

Karoline Aebi-Popp

Serum lipid and glucose profiles in HIV-positive Nigerian children

Olukemi O Ige, Christopher S Yilgwan, Augustine O Ebonyi, Ruth Adah, Idris Adedeji, Esther S Yiltok, Stephen Oguche, Fidelia Bode-Thomas

HIV cure research community engagement in North Carolina: a mixed-methods evaluation of a crowdsourcing contest

Allison Mathews, Samantha Farley, Meredith Blumberg, Kimberley Knight, Lisa Hightow-Weidman, Kate Muessig, Stuart Rennie, Joseph Tucker

Factors associated with clinic escorts in peer-led HIV prevention interventions for men who have sex with men (MSM) in Sri Lanka

M Suchira Suranga, DA Karawita, SMAS Bandara, RMDK Rajakaruna

Safety of lumbar puncture procedure in an international research setting during acute HIV infection

Philip Chan, Joanna Hellmuth, Donn Colby, Eugene Kroon, Carlo Sacdalan, James Fletcher, Payal Patel, Suteera Pinyakorn, Victor Valcour, Jintanat Ananworanich, Serena Spudich

Pursuing ethical coherence in the prevention of vertical transmission of HIV: justice and injustice in Option B+

Nathan Hodson & Susan Bewley

HIV cure research: print and online media reporting in Australia

Jennifer Power, Bianca Fileborn, Gary W Dowsett, Jayne Lucke, Graham Brown, Jeanne Ellard, Sharon R Lewin, Joseph D Tucker, Sean Slavin, Jeremy Sugarman, Sophie Hill

Twenty-two years of HIV infection in Bhutan: epidemiological profile

Pandup Tshering, Karma Lhazeen, Sonam Wangdi, Namgay Ushering

Hepatitis E virus in developed countries

Harry Dalton, Maria Saunders, Kathy L Woolson

Treatment outcomes of first-line antiretroviral therapy in HIV-1-positive patients in Serbia

J Kušic, M Mladenovic, B Dimitrijevic, et al.

Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam

S Rangarajan, DJ Colby, G Le Truong, et al.

Quantifying integrated SIV-DNA by repetitive-sampling Alu-gag PCR

Maud Mavigner, S Thera Lee, Jakob Habib, Cameron Robinson, Guido Silvestri, Una O'Doherty, Ann Chahroudi

Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women

W van Snippenburg , FJB Nellen , C Smit , AMJ Wensing , MH Godfried , T Mudrikova

Highlights from the HIV Research for Prevention Conference (R4P), 17–21 October 2016, Chicago, IL, USA

Sandhya Vasan, Tanyaporn Wansom, Alexandra Schuetz, Shelly Krebs, Rasmi Thomas, Gustavo Kijak, Christina Polyak

Scaling up HIV self-testing in China and Africa

Joseph D Tucker, J Ong, D Conserve, S Pan, W Tang

Markers of subclinical atherosclerotic disease in HIV-infected individuals

Pulin Gupta, Manu Gupta, Anil Taneja, Rajesh Taneja, Bharat Rewari, Ashok Lal

Converging roads: the latest science from the 2017 IAS HIV Cure and Cancer Forum

Genevieve E Martin, José Alcami, Jean-Philippe Spano, Anna Laura Ross

New prospects for a preventive HIV-1 vaccine

Jeffrey Brown, Jean-Louis Excler, Jerome H Kim

Factors associated with HIV RNA viral loads in ART-naïve patients: implications for treatment as prevention in concentrated epidemics

S Rangarajan, D Colby, G Le Truong, et al.

Response to hepatitis B vaccination among HIV-infected adults in Vietnam

TM Pollack, LTT Trang, L Ngo, DD Cuong, PT Thuy, DJ Colby

Impact of orphan status on HIV treatment outcomes and retention in care of children and adolescents in Asia

Bui Vu Huy, Sirinya Teeraananchai, Le Ngoc Oath, et al. on behalf of the TREAT Asia Pediatric HIV Observational Database

Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US

Karine Dubé, David Evans, Laurie Sylla, Jeff Taylor, Bryan J Weiner, Asheley Skinner, Harsha Thirumurthy, Joseph D Tucker, Stuart Rennie, Sandra B Greene

Highlights of the International Congress on Drug Therapy in HIV Infection, 23–26 October 2016, Glasgow, UK

Julio Montaner, Pablo Rojo, Tarandeep Anand, Jurgen Rockstroh

Highlights from the 9th IAS Conference on HIV Science, 23–26 July 2017, Paris, France

Christina K Psomas, Tristan J Barber, Sofie Rutsaert, Sabine Kinloch-de Loës

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines

Edwina Wright, Andrew Grulich, Katy Roy, Mark Boyd, Vincent Cornelisse, Darren Russell, Darryl O‘Donnell, Bill Whittaker, Levinia Crooks, Iryna Zablotska

Dermatological conditions associated with HIV medication in a cohort of Greek patients initiating antiretroviral therapy: 1988–2013

Iliana Alexoudi, Alexandra Katsarou, Vassileios Paparizos, Sofia Kourkounti, Georgia Augerinou, Christina Antoniou

HIV self-testing among key populations: an implementation science approach to evaluating self-testing

Joseph D Tucker, Chongyi Wei, Razia Pendse, Ying-Ru Lo

Low incidence of HIV infection in an anonymous HIV counselling and testing clinic cohort in Bangkok, Thailand despite high HIV prevalence and self-report of high-risk behaviour

Nittaya Phanuphak, Robert Paris, Donn Colby et al.

Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection

J Ananworanich, CP Sacdalan, S Pinyakorn, et al.

History of the prevention of mother-to-child transmission of HIV in Thailand

Nittaya Phanuphak & Praphan Phanuphak

Twin pregnancy in a liver transplant recipient with HIV infection

MCI Van Schalkwyk, RH Westbrook, J O'Beirne, A Wright, A Gonzalez, MA Johnson, S Kinloch-de Loës

Demographic and clinical correlates of HIV-1 RNA levels in antiretroviral therapy-naive adults attending a tertiary hospital in Jos, Nigeria

Joseph Anejo-Okopi, Isaac Okoh Abah , Yakhat Barshep, Augustine Odo Ebonyi , Comfort Daniyam, Samson Ejiji Isa, Gomerep Simji, Stephen Oguche, Patricia Agaba, Oche Agbaji , John A Idoko, Patricia Lar

Highlights from the 24th Conference on Retroviruses and Opportunistic Infections 13–16 February 2017, Seattle, Washington, USA

Trevor A Crowell , Hermione Lyall, Eva Malatinkova, Sanjay Bhagani, Denise Hsu, Donn J Colby, Christina Polyak, Christina Psomas, Andrew Hill, Esther N Gathogo, Wim Trypsteen, Linos Vanderkerckhove, Sabine Kinloch

Highlights from the BHIVA Satellite Symposium, IAS Conference, Paris, France, July 2017: ‘Tougher times: adapting to increasing demand with declining resources’

Valerie Delpech, Nneka Nwokolo, Laura Waters, Angelina Namiba, Chloe Orkin

Crowdsourcing and community engagement: a qualitative analysis of the 2BeatHIV contest

Allison Mathews, Samantha Farley, Lisa Hightow-Weidman, Kate Mussig, Stuart Rennie, Joseph D Tucker

Highlights for the 9th International Workshop on Pediatrics, 22–23 July 2017, Paris, France

Natella Rakhmanina, Alfredo Tagarro, Lizzie Chappell, Siobhan Crichton, Steve Innes, Mark Cotton, Ann Chahroudi, Sam Fry, Virginia Rasi, Shaun Barnabas, Claire Thorne, Amy L Slogrove, Wipaporn Natalie Songtaweesin, Thanyawee Puthanakit

Cervical cytological abnormalities and HPV infection in perinatally HIV-infected adolescents

Jintanat Ananworanich, W Prasitsuebsai, SJ Kerr

Recruitment and ethical considerations in HIV cure trial requiring treatment interruption

Michael P Arnold, David Evans, Nelson Vergel

Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand

Reshmie A Ramautarsing & Nittaya Phanuphak et al.

Women in HIV cure research: multilevel interventions to improve sex equity in recruitment

ME Grewe, Y Ma, A Gilbertson, et al.

Ethical, strategic and meaningful involvement of women living with HIV starts at the beginning

A Namiba, L Orza, S Bewley, ET Crone, M Vazquez, A Welbourn

The latest science from the IAS Towards an HIV Cure Symposium 16–17 July 2016, Durban, South Africa

Jaclyn Mann, Alexander O Pasternak, Ann Chahroudi, Jerome A Singh, Anna Laura Ross

Bone mineral density optimisation in adults with perinatally acquired HIV infection in routine care

Thomas J Pasvol, Fred Fyle, Caroline Foster, Sarah Fidler

Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India

Nagalingeswaran Kumarasamy, Sruthi Sundaram, Selvamuthu Poongulali, Chandrasekaran Ezhilarasi, Ambrose Pradeep, Devara Chitra

Community participation in HIV cure research: perspectives from Thailand

Nittaya Phanuphak, Nimitr Tien-Udom, Praphan Phanuphak

Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries

Andrew Hill, Dzintars Gotham, Graham Cooke et al.

Human breast milk: is it the best milk to prevent HIV transmission?

Paolo Palma

HIV persistence in the CNS: the final frontier for a cure?

Sharon R Lewin & John W Mellors

Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T cells

Zhe Yuan, Guobin Kang, Wuxun Lu, Qingsheng Li

Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland

K Aebi-Popp, A Duppenthaler, A Rauch, et al.

Abstracts of the Seventh International Workshop on HIV Persistence during Therapy

What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent

Holly L Peay & Gail E Henderson

Innovative strategies using communications technologies to engage gay men and other men who have sex with men into early HIV testing and treatment in Thailand

Tarandeep Anand & Chattiya Nitpolprasert, et al.

The menopause transition in women living with HIV: current evidence and future avenues of research

S Tariq, J Anderson, F Burns, V Delpech, R Gilson, C Sabin

Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA

Jeymohan Joseph, Paola Cinque, Deborah Colosi, et al.

HIV Reservoir Characterization Symposium, 19 September 2016, Ghent, Belgium

Eva Malatinkova, Ward De Spiegelaere, Linos Vandekerckhove, Magdalena Sips

Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children‘s Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9–11 November 2017, Rome, Italy

P Zangari, P Palma, N Cotugno, P Rojo, A Tagarro, I Pepponi, A De Rossi, L Kuhn, S Pahwa, M Cameron, E Nastouli, S Watters, AG Marceline, LE McCoy, D Persaud, A Violari, M Chan, AG Babiker, C Foster, J Ananworanich, C Giaquinto, P Rossi

Is there gender bias in HIV cure research?

R Johnston, S Pinyakorn, J Ananworanich

Abstracts of the HIV Reservoir Characterization Symposium

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification

Jintanat Ananworanich, Nicolas Chomont, JLK Fletcher et al

Highlights from the Third Biennial Strategies for an HIV Cure Meeting, 14–16 November 2016, Bethesda, MD, USA

Diane Lawrence, Lillian Kuo, Elizabeth Church, Betty Poon, Stephen Smiley, Brigitte Sanders-Beer, Liza Dawson, Karl Salzwedel

Highlights from the HTLV-1 symposium at the 2017 Australasian HIV and AIDS Conference held jointly with the 2017 Australasian Sexual Health Conference, November 2017, Canberra, Australia

Lloyd Einsiedel, Damian Purcell, Shane Schinke, Katelin Haynes, Graham P Taylor, Fabiola Martin

HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART

Tanya Do, Kerr Stephen, Anchalee Avihingsanon, Saowaluk Suksawek, Supalak Klungkang, Taweesak Channgam, Christoph Odermatt, Wirach Meek-a-nantawat, Kiat Ruxtungtham, Jintanat Ananworanich, Victor Valcour, Peter Reiss, Ferdinand Wit

Conference on Retroviruses and Opportunistic Infections 2015

Jintanat Ananworanich, Linos Vanderkerckhove, Ya-Chi Ho, Claudia Alteri et al.

The evolving role of interferons in viral eradication strategies

Tomas Doyle

Highlights from the HIV Cure and Reservoir Symposium, 11–12 September 2017, Ghent, Belgium

Sam Kint, Clarissa Van Hecke, Basiel Cole, Linos Vandekerckhove, Magdalena Sips

Art and viral hepatitis elimination programmes

Maryam Nima, Hamidreza Karimi-Sari, Seyed Alavian

Highlights from the Conference on Retroviruses and Opportunistic Infections 2016 22–25 February 2016, Boston, Massachusetts, USA

S Fidler, J Ananworanich, L Vandekerckhove, M Kiselinova, A Schuetz, JH Vera, E Dwyer, J Alagaratnam

Highlights from HIV Research Prevention (R4P)

Julie Ake

We all need to know about HIV cure research: a case report

Olubanke Davies & Julie Fox